Barry G, Briggs JA, Vanichkina DP, Poth ME, Beveridge NJ, Ratnu VS, Nayler SP, Nones K, Hu J, Bredy TW, Nakagawa S, Rigo F, Taft RJ, Cairns MJ, Blackshaw S, Wolvetang EJ, Mattick JS. (2013) The long non-coding RNA Gomafu is acutely regulated in response to neuronal activation and involved in schizophrenia-associated alternative splicing. Mol. Psych . (in press).
Simon AK, Prescott M, Menendez J, Liu F, Wang F, Wang C, Wolvetang EJ, Vazquez-Martin A, Zhang J. (2013) Autophagy in stem cells. Autophagy (Accepted for publication).
Briggs JA, Mason E, Ovchinnikov DA, Wells CA, Wolvetang EJ. (2012) New paradigms for Down syndrome research using iPSCs: tackling complex human genetic disease. Stem cells Translational Medicine (in press).
Sin DC, Fitzpatrick J, Luckman P, Wolvetang EJ, Cooper-White JJ. (2012) Fabrication of nanopatterned, porous microspheres using a glass capillary microfluidic device. Soft Matter (in Press).
Titmarsh DM, Hudson JE, Hidalgo A, Elefanty AG, Stanley EG, Wolvetang EJ, Cooper-White JJ. (2012) Microbioreactor Arrays for Full Factorial Screening of Exogenous and Paracrine Factors in Human Embryonic Stem Cell Differentiation. PLOS One 7(12).
Vitale AM, Matigian NA, Ravishankar S, Bellette B, Wood SA, Wolvetang EJ, Mackay-Sim A. (2012) Variability in the generation of induced pluripotent stem cells: Importance for disease modelling. Stem cells Translational Medicine 1(9), 641-650.
Briggs JA, Sun J, Shepherd J, Ovchinnikov DA, Chung TL, Nayler SP, Kao LP, Morrow CA, Thakar NY, Soo SY, Peura T, Grimmond SM, Wolvetang EJ. (2012) Integration-free iPS cells identify genetic and neural developmental features of Down syndrome etiology. Stem Cells. (accepted)
Titmarsh DM, Chen H, Wolvetang EJ, Cooper-White JJ. (2012) Arrayed cellular environments for stem cells and regenerative medicine. Biotechnology Journal 2013 (8).
Tra T, Gong L, Kao L-P, Li X-L, Grandela C, Devenish RJ, Prescott M, Wolvetang EJ. (2011) Autophagy in human embryonic stem cells. PLOS One 6(11), e27485. Epub 2011, Nov 14.
Jaramillo-Ferrada P, Wolvetang EJ, Cooper-White JJ. (2011) Differential mesengenic potential and expression of stem cell fate modulators in mesenchymal stromal cells from human term placenta and bone marrow. Journal of Cellular Physiology 227(9),3234-3242.
Chen YS, Pelekanos RA, Ellis RL, Horne R, Wolvetang EJ, Fisk NM. (2011) Small Molecule Mesengenic Induction of Human Induced Pluripotent Stem Cells to Generate Mesenchymal Stem/ Stromal Cells. Stem Cells Translational Medicine 1, 83-95.
Nayler SP, Gatei M, Kozlov S, Gatti R, Mar JC, Wells CA, Lavin M, Wolvetang EJ. (2012) Induced pluripotent stem cells from ataxia-telangiectasia recapitulate the cellular phenotype. Stem cells Translational Medicine 1, 523-535.
Ovchinnikov DA, Turner JP, Titmarsh DM, Thakar NY, Sin DC, Cooper-White JJ, Wolvetang EJ. (2012) Generation of a human embryonic stem cell line stably expressing high levels of the fluorescent protein mCherry. World Stem Cell Journal 4(7), 71-79.
Whitworth DJ, Ovchinnikov DA, Wolvetang EJ. (2012) Generation and Characterization of LIF-dependent Canine Induced Pluripotent Stem Cells from Adult Dermal Fibroblasts. Stem Cells Dev 21(12), 2288-2297.
Titmarsh DM, Hidalgo-Gonzalez A, Turner JP, Wolvetang EJ, Cooper-White JJ. (2011) Optimisation of Flowrate for Expansion of Human Embryonic Stem Cells in Perfusion Microbioreactors. Biotechnology and Bioengineering 108(12), 2894-904.
Hudson JE, Titmarsh DM, Hidalgo A, Wolvetang EJ, Cooper-White JJ. (2011) Primitive Cardiac Cells from Human Embryonic Stem Cells. Stem Cells and Development 10 21(9), 1513-23.
Vitale AM, Wolvetang EJ, Mackay-Sim A. (2010) Induced pluripotent cells: a new technology to study human diseases. The International Journal of Biochemistry and Cell Biology 43(6), 843-6. Epub 2011, Mar 31.
Prowse A, Doran M, Cooper-White JJ, Chong F, Munro TP, Fitzpatrick J, Chung TL, Haylock DN, Gray PP, Wolvetang EJ. (2010) Long term culture of human embryonic stem cells on recombinant vitronectin in ascorbate free media. Biomaterials 31(32), 8281-8288.
Chung T-L, Brena RM, Kolle G, Grimmond SM, Berman BP, Laird PW, Pera MF, Wolvetang EJ. (2010) Vitamin C promotes widespread yet specific demethylation of the hESC epigenome. Stem Cells 28(10), 1848-1855.
Chung T-L, Turner JP, Thakar NY, Kolle G, Cooper-White JJ, Grimmond SM, Pera MF, Wolvetang EJ. (2010) Ascorbate Promotes Epigenetic activation of CD30 in Human Embryonic Stem Cells. Stem Cells 28(10), 1782-1793.
Hannan NRF, Jamshidi P, Pera MF, Wolvetang EJ. (2009) BMP -11 and Myostatin Maintain Human Embryonic Stem Cells in Feeder Free Cultures. Cloning and Stem Cells 11(3), 427-435.
Hannan NRF, Wolvetang EJ. (2008) Adipocyte differentiation in human embryonic stem cells transduced with Oct4 shRNA lentivirus. Stem Cell Dev 18(4), 653-660.
Wolvetang EJ, Pera MF, Zuckerman KS. (2007) Gap-junction mediated transport of shRNA between human embryonic stem cells. Biochem Biophys Res Comm 363(3), 610-615.
Grandela C, Pera MF, Grimmond SM, Kolle G, Wolvetang EJ. (2007) p53 is required for etoposide-induced apoptosis of human embryonic stem cells. Stem Cell Research 1(2), 116-128.
Wolvetang EJ,Herszfeld D, Langton–Bunker E, Chung T-L, Filipczyk A, Houssami S, Koh K, Laslett AL, Michalska A, Nguyen L, Reubinoff BE, Tellis I, Auerbach JM, Ording CJ, Looijenga LHJ, Pera MF. (2006) CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells. Nat Biotech 24(3), 351-357.
Helguera P, Pelsman A, Pigino G, Wolvetang EJ, Head E, Busciglio J. (2005) Ets-2 Promotes the Activation of a Mitochondrial Death Pathway in Down's Syndrome Neurons. J Neurosci 25(9), 2295-2303.

On this site

Go to top